Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira Jacobs

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
The Oncologist|May 18, 2018
Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and TrustEduardo Cazap, Ira Jacobs, Ali McBride, et al.
JMIR Formative Research|March 24, 2022
Accelerating Virtual Health Implementation Following the COVID-19 Pandemic: Questionnaire StudyMelissa Stahl, James Cheung, Kevin Post, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 17, 2017
Drug tendering: drug supply and shortage implications for the uptake of biosimilarsGeorge Dranitsaris, Ira Jacobs, Carol Kirchhoff, et al.
Pharmacoeconomics|June 30, 2017
Assessing the Value of Biosimilars: A Review of the Role of Budget Impact AnalysisSteven Simoens, Ira Jacobs, Robert Popovian, et al.
Journal of the Advanced Practitioner in Oncology|June 29, 2019
Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in OncologySara M Tinsley, Carolyn Grande, Karin Olson, et al.
Plos One|March 4, 2017
Rate dependent influence of arterial desaturation on self-selected exercise intensity during cyclingSaro D Farra, Stephen S Cheung, Scott G Thomas, et al.
Postgraduate Medicine|March 28, 2017
Biosimilar biologic drugs: a new frontier in medical careDaniel M Geynisman, Guillermo De Velasco, K Lea Sewell, et al.
Gynecologic Oncology Research and Practice|March 28, 2017
Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?Bradley J Monk, Warner K Huh, Julie Ann Rosenberg, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 26, 2016
Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published EvidenceIra Jacobs, Danielle Petersel, Leah Isakov, et al.
Respiratory Physiology & Neurobiology|May 29, 2016
Clamping end-tidal carbon dioxide during graded exercise with control of inspired oxygenSaro D Farra, Cathie Kessler, James Duffin, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
The Oncologist|May 18, 2018
Global Acceptance of Biosimilars: Importance of Regulatory Consistency, Education, and TrustEduardo Cazap, Ira Jacobs, Ali McBride, et al.
JMIR Formative Research|March 24, 2022
Accelerating Virtual Health Implementation Following the COVID-19 Pandemic: Questionnaire StudyMelissa Stahl, James Cheung, Kevin Post, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 17, 2017
Drug tendering: drug supply and shortage implications for the uptake of biosimilarsGeorge Dranitsaris, Ira Jacobs, Carol Kirchhoff, et al.
Pharmacoeconomics|June 30, 2017
Assessing the Value of Biosimilars: A Review of the Role of Budget Impact AnalysisSteven Simoens, Ira Jacobs, Robert Popovian, et al.
Journal of the Advanced Practitioner in Oncology|June 29, 2019
Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in OncologySara M Tinsley, Carolyn Grande, Karin Olson, et al.
Plos One|March 4, 2017
Rate dependent influence of arterial desaturation on self-selected exercise intensity during cyclingSaro D Farra, Stephen S Cheung, Scott G Thomas, et al.
Postgraduate Medicine|March 28, 2017
Biosimilar biologic drugs: a new frontier in medical careDaniel M Geynisman, Guillermo De Velasco, K Lea Sewell, et al.
Gynecologic Oncology Research and Practice|March 28, 2017
Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?Bradley J Monk, Warner K Huh, Julie Ann Rosenberg, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 26, 2016
Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published EvidenceIra Jacobs, Danielle Petersel, Leah Isakov, et al.
Respiratory Physiology & Neurobiology|May 29, 2016
Clamping end-tidal carbon dioxide during graded exercise with control of inspired oxygenSaro D Farra, Cathie Kessler, James Duffin, et al.
Pageof 9